knowledge -WSS

knowledge

author：hotspot 2025-10-01 07:40:12 - browse：21918

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： 'Make People Better': The CRISPR babies story you probably don't know

WSS

Pharma budget tightening trickles down to Doximity

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Ethical issues complicate the benefits of medical crowdfunding

White House drug shortages task force keeps mum with Congress

Timeline: Special counsel's investigation into Trump's handling of classified documents

Timeline: Special counsel's investigation into Trump's handling of classified documents

entertainment

knowledge

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medicaid rebukes states for mistakenly disenrolling children

Wildfire smoke exposes gaps in outdoor worker protections

How to fix cancer clinical trials' diversity problem

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A new House health package & hospitals’ new site

United colonoscopy coverage change 'may cost lives,' doctors say

How to fix cancer clinical trials' diversity problem

Malaria cases in Florida and Texas: Here’s what you need to know

Snackable artificial intelligence, expert AI, and the pharma industry

focus

Snackable artificial intelligence, expert AI, and the pharma industry

GOP presidential candidates start declaring their loyalty

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

TB outbreak tied to bone grafts underscores testing shortcomings

The (many) problems with a new study criticizing cancer screening

knowledge

knowledge

leisure time

hotspot